Journals / Haydarpaşa Numune Medical Journal / 2019 / Cilt: 59 - Sayı: 2

The Relationship Between Plasma Adipsin, Adiponectin, Vaspin, Visfatin, and Leptin Levels with Glucose Metabolism and Diabetes Parameters

Pages
95–103
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion and Conclusion: In the diabetic rat model, body weight, glucose metabolism enzymes, insulin sensitivity, and changes in plasma adipsin, adiponectin, vaspin, visfatin, and leptin levels indicate that these adipokines play an important role in the glucose metabolism, insulin resistance, and pathogenesis of diabetes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Recently, interesting adipokines have been described that affect glucose metabolism and insulin resistance.
📊
Key Findings & Data:Methods: Wistar albino rats were divided into three groups: control, diabetic control, and treatment groups, each with 7 of them.
💡
Conclusion & Impact:Discussion and Conclusion: In the diabetic rat model, body weight, glucose metabolism enzymes, insulin sensitivity, and changes in plasma adipsin, adiponectin, vaspin, visfatin, and leptin levels indicate that these adipokines play an important role in the glucose metabolism, insulin resistance, and pathogenesis of diabetes.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Introduction: Recently, interesting adipokines have been described that affect glucose metabolism and insulin resistance. However, the relationships between these adipokines and their importance in the pathogenesis of diabetes are contradictory. The aim of the present study was to investigate the relationship between plasma adipsin, adiponectin, vaspin, visfatin, and leptin levels in diabetic rats with liver enzymes related to glucose metabolism and diabetes parameters. Methods: Wistar albino rats were divided into three groups: control, diabetic control, and treatment groups, each with 7 of them. One group of diabetic rats was orally treated with 200 mg/kg/day metformin, and the other diabetic group received placebo. After 6 weeks, the animals were sacrificed by cardiac puncture. Glucose, insulin, glycosylated hemoglobin (HbA1c), adipsin, adiponectin, visfatin, vaspin, and leptin levels in blood were measured by enzyme-linked immunosorbent assay (ELISA), and insulin resistance was determined. In liver homogenates, glucose-6-phosphate dehydrogenase (G6PD), glucose- 6-phosphatase (G6P-ase), glucokinase, pyruvate kinase (PK), and fructose-1.6-diphosphatase (F1.6DP) activities were measured by ELISA. Results: Dietary food intake and water consumption, fasting blood glucose and HbA1c levels, and insulin resistance of diabetic rats were higher than those of the control and treatment groups. Plasma adipsin, adiponectin, vaspin, and leptin levels significantly decreased, and visfatin level increased in diabetic rats. G6PD, glucokinase, and PK activities decreased, whereas G6P-ase and F1.6DP activities increased in diabetic rats. There were a negative correlation between plasma adipsin and adiponectin levels and insulin resistance and a positive correlation between visfatin level and insulin resistance in diabetic rats. In addition, adipsin, adiponectin, and leptin levels were positively correlated with each other and with some liver enzymes. Discussion and Conclusion: In the diabetic rat model, body weight, glucose metabolism enzymes, insulin sensitivity, and changes in plasma adipsin, adiponectin, vaspin, visfatin, and leptin levels indicate that these adipokines play an important role in the glucose metabolism, insulin resistance, and pathogenesis of diabetes.

🔖

Cite This Article

TAŞDEMİR, E., ŞERMET, A. (2019). The Relationship Between Plasma Adipsin, Adiponectin, Vaspin, Visfatin, and Leptin Levels with Glucose Metabolism and Diabetes Parameters. Haydarpaşa Numune Medical Journal, Cilt: 59 - Sayı: 2, 95–103. https://ajindex.com/articles/190427

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO. Obesity, inactivity, and the prevalence of diabetes and diabetes- related cardiovascular comorbidities in the U.S., 2000- 2002. Diabetes Care 2005
  2. 1599–603. [CrossRef ] 2. Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, et al. The evolving diabetes burden in the United States. Ann Intern Med 2004
  3. 945–50. [CrossRef ] 3. Watal G, Dhar P, Srivastava SK, Sharma B. Herbal medicine as an alternative medicine for treating diabetes: the global burden. Evid Based Complement Alternat Med 2014
  4. 596071. 4. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005
  5. 1333–46. [CrossRef ] 5. Ahima RS. Adipose tissue as an endocrine organ. Obesity (Silver Spring) 2006
  6. 14 Suppl 5:242S–9S. [CrossRef ] 6. Pfeifer A, Hoffmann LS. Brown, beige, and white: the new color code of fat and its pharmacological implications. Annu Rev Pharmacol Toxicol 2015
  7. 207–27. [CrossRef ] 7. Fasshauer M, Blüher M. Adipokines in health and disease. Trends Pharmacol Sci 2015
  8. 461–70. [CrossRef ] 8. Falcão-Pires I, Castro-Chaves P, Miranda-Silva D, Lourenço AP, Leite-Moreira AF. Physiological, pathological and potential therapeutic roles of adipokines. Drug Discov Today 2012
  9. 880–9. [CrossRef ] 9. Rajkovic N, Zamaklar M, Lalic K, Jotic A, Lukic L, Milicic T, et al. Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention. Int J Environ Res Public Health 2014
  10. 4049– 65. [CrossRef ] 10. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006
  11. 1357–62. [CrossRef ] 11. Cook KS, Min HY, Johnson D, Chaplinsky RJ, Flier JS, Hunt CR, et al. Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science 1987
  12. 402–5. 12. White RT, Damm D, Hancock N, Rosen BS, Lowell BB, Usher P, et al. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem 1992
  13. 9210–3. 13. Lo JC, Ljubicic S, Leibiger B, Kern M, Leibiger IB, Moede T, et al. Adipsin is an adipokine that improves β cell function in diabetes. Cell 2014
  14. 41–53. [CrossRef ] 14. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, et al. An